WJA
BMY icon

Williams Jones & Associates’s Bristol-Myers Squibb BMY Stock Holding History

Williams Jones & Associates’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		$8.1M Sell
178,604
-10,686
-6% -$498K 0.17% 89
2019
Q1 		$9.03M Sell
189,290
-131,641
-41% -$6.56M 0.2% 81
2018
Q4 		$16.7M Sell
320,931
-14,720
-4% -$791K 0.45% 56
2018
Q3 		$20.8M Sell
335,651
-9,011
-3% -$535K 0.42% 64
2018
Q2 		$19.1M Sell
344,662
-18,648
-5% -$1.01M 0.42% 66
2018
Q1 		$23M Buy
363,310
+1,910
+0.5% +$123K 0.53% 54
2017
Q4 		$22.1M Buy
361,400
+227
+0.1% +$14.2K 0.5% 58
2017
Q3 		$23M Sell
361,173
-445
-0.1% -$26K 0.57% 54
2017
Q2 		$20.1M Sell
361,618
-3,857
-1% -$210K 0.51% 55
2017
Q1 		$19.9M Sell
365,475
-160,229
-30% -$8.79M 0.52% 54
2016
Q4 		$30.7M Sell
525,704
-67,550
-11% -$3.69M 0.88% 34
2016
Q3 		$32M Buy
593,254
+122,586
+26% +$7.87M 0.94% 34
2016
Q2 		$34.6M Buy
470,668
+74,372
+19% +$5.26M 1.07% 30
2016
Q1 		$25.3M Buy
396,296
+6,125
+2% +$386K 1.18% 25
2015
Q4 		$26.8M Sell
390,171
-2,090
-0.5% -$138K 1.23% 23
2015
Q3 		$23.2M Buy
392,261
+909
+0.2% +$57.7K 1.05% 29
2015
Q2 		$26M Sell
391,352
-5,455
-1% -$359K 1% 28
2015
Q1 		$25.6M Sell
396,807
-1,325
-0.3% -$83K 1.03% 26
2014
Q4 		$23.5M Buy
398,132
+1,775
+0.4% +$100K 0.96% 28
2014
Q3 		$20.3M Sell
396,357
-9,163
-2% -$458K 0.93% 34
2014
Q2 		$19.7M Sell
405,520
-963,566
-70% -$47.5M 0.88% 34
2014
Q1 		$71.1M Buy
1,369,086
+678,704
+98% +$36.1M 1.43% 15
2013
Q4 		$36.7M Sell
690,382
-49,006
-7% -$2.5M 1.76% 16
2013
Q3 		$34.2M Sell
739,388
-15,742
-2% -$691K 1.77% 18
2013
Q2 		$33.7M Buy
+755,130
New +$32.8M 1.68% 13

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Williams Jones & Associates's BMY Position: Q2 2019 in Review

Williams Jones & Associates reduced its Bristol-Myers Squibb (BMY) stake by 5.6% in Q2 2019, selling an estimated $498K and leaving 178,604 shares worth $8.1M. The position accounts for 0.17% of the portfolio, ranked #89.

Williams Jones & Associates first reported a position in BMY in Q2 2013 and has held it in 25 quarters since. The position peaked at $71.1M in Q1 2014. 1,777 funds tracked by Wall St. Rank hold BMY as of Q2 2019.

  • Williams Jones & Associates held 178,604 shares of Bristol-Myers Squibb worth $8.1M as of Q2 2019.
  • Williams Jones & Associates sold 10,686 Bristol-Myers Squibb shares in Q2 2019, an estimated $498K.
  • Bristol-Myers Squibb made up 0.17% of Williams Jones & Associates's portfolio in Q2 2019, its #89 holding.
  • Williams Jones & Associates first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 25 quarters since.
  • Williams Jones & Associates's Bristol-Myers Squibb position peaked at $71.1M in Q1 2014.
  • 1,777 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2019.

Based on Williams Jones & Associates's 13F filing for Q2 2019, filed 14 Aug 2019.